Clinical Trial: Phase I/II study evaluating the safety, tolerability, and efficacy of sacituzumab govitecan administered on day 1 and day 8 in combination with pegfilgrastim on day 2 in patients with unresectable or recurrent HER2-negative breast cancer (Japan)

Posted On: 2026-08-21

Health & Lifestyle Health Daily Digest Online News

Tokyo, Aug. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062648) titled 'Phase I/II study evaluating the safety, tolerability, and efficacy of sacit... Read More

Clinical Trial: Effects of pre-exercise protein ingestion on performance and executive function (Japan)

Posted On: 2026-08-21

Health & Lifestyle Health Daily Digest Online News

Tokyo, Aug. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062645) titled 'Effects of pre-exercise protein ingestion on performance and executive func... Read More

Clinical Trial: A birth cohort observational study of skin factors associated with the development of infantile atopic dermatitis (Japan)

Posted On: 2026-08-21

Health & Lifestyle Health Daily Digest Online News

Tokyo, Aug. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062644) titled 'A birth cohort observational study of skin factors associated with the deve... Read More

Clinical Trial: A safety study: an open-label study (Japan)

Posted On: 2026-08-21

Health & Lifestyle Health Daily Digest Online News

Tokyo, Aug. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062642) titled 'A safety study: an open-label study' on Aug. 21. Study Type: Intervention... Read More

Clinical Trial: Effectiveness of radial extracorporeal shockwave therapy (rESWT) for post-stroke shoulder pain: a randomized controlled trial (Japan)

Posted On: 2026-08-21

Health & Lifestyle Health Daily Digest Online News

Tokyo, Aug. 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062615) titled 'Effectiveness of radial extracorporeal shockwave therapy (rESWT) for should... Read More

Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Posted On: 2026-08-20

Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembr... Read More

Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Posted On: 2026-08-20

Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More

Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Posted On: 2026-08-20

Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Com... Read More

Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Posted On: 2026-08-20

Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared w... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Posted On: 2026-08-20

Health & Lifestyle Health Daily Digest Online News

Singapore, Aug. 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemothera... Read More

Exclusive

Category

Source

Publication

Byline

Location

Clinical Trial: Phase I/II study evaluating the safety, tolerability, and efficacy of sacituzumab govitecan administered on day 1 and day 8 in combination with pegfilgrastim on day 2 in patients with unresectable or recurrent HER2-negative breast cancer (Japan)

Clinical Trial: Effects of pre-exercise protein ingestion on performance and executive function (Japan)

Clinical Trial: A birth cohort observational study of skin factors associated with the development of infantile atopic dermatitis (Japan)

Clinical Trial: A safety study: an open-label study (Japan)

Clinical Trial: Effectiveness of radial extracorporeal shockwave therapy (rESWT) for post-stroke shoulder pain: a randomized controlled trial (Japan)

Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)